Business
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
SANTA CLARA, Calif., May 06, 2025--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
About this update from Heartbeam, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/cb4c6da553ab1cbd666d5391037cf5af"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0osOGq3psAM5M6wUirlsdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cb4c6da553ab1cbd666d5391037cf5af","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/mfAX.G6vhRPrY4ybDu9rQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/cb4c6da553ab1cbd666d5391037cf5af","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"First patent significantly advances intellectual property for HeartBeam’s credit card-sized ECG device, bolstering both the defensive and offensive moat around the company’s core technology","length":189,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Second patent expands the use of risk-based diagnostic algorithms into HeartBeam’s product portfolio around wearable devices","length":124,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"HeartBeam now has 20 issued patents worldwide, cementing Company’s leadership in cardiac monitoring innovation","length":110,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":423,"olType":false},{"type":"text","content":"SANTA CLARA, Calif., May 06, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced the addition of two new U.S. patents, reinforcing its core intellectual property position and enabling future product extensions. The patents reinforce HeartBeam’s groundbreaking innovations and further solidify the Company’s intellectual property (IP) footprint in cardiac monitoring technology that bring advanced cardiac insights to patients and clinicians.","length":571,"tagName":"p"},{"type":"text","content":"The first patent protects IP around HeartBeam’s credit card-sized, cable-free 3D ECG device. Designed for ease of use, the device features chest and finger electrodes to capture high-fidelity electrical signals in 3D (by capturing 3 non-coplanar dire...